The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 90, n. 2, p. 288–299, 2019. DOI: 10.23750/abm.v90i2.8340. Disponível em: https://mattioli1885journals.com/index.php/actabiomedica/article/view/8340.. Acesso em: 30 jun. 2024.